Compass Therapeutics (CMPX) Short Interest Ratio & Short Volume → A ‘DeFi Summer’ Projected! (From Crypto 101 Media) (Ad) Free CMPX Stock Alerts $1.54 -0.07 (-4.35%) (As of 05/15/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Compass Therapeutics Short Interest DataCurrent Short Volume1,640,000 sharesPrevious Short Volume1,620,000 sharesChange Vs. Previous Month+1.23%Dollar Volume Sold Short$2.36 millionShort Interest Ratio / Days to Cover4.6Last Record DateApril 30, 2024Outstanding Shares137,590,000 sharesFloat Size86,210,000 sharesShort Percent of Float1.90%Today's Trading Volume684,157 sharesAverage Trading Volume443,801 sharesToday's Volume Vs. Average154% Short Selling Compass Therapeutics ? Sign up to receive the latest short interest report for Compass Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatCMPX Short Interest Over TimeCMPX Days to Cover Over TimeCMPX Percentage of Float Shorted Over Time Ad Chaikin AnalyticsThis Wall Street stock prediction just went viralPeople around the world follow 50-year Wall Street veteran Marc Chaikin for his surprisingly accurate stock predictions. And he just issued an urgent WARNING for some of the most popular stocks in U.S. history.Watch just the first 5 minutes of his new prediction Compass Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20241,640,000 shares $2.36 million +1.2%1.9%4.6 $1.44 4/15/20241,620,000 shares $2.56 million No Change1.9%4.4 $1.58 3/31/20241,620,000 shares $3.21 million -13.8%2.0%3.3 $1.98 3/15/20241,880,000 shares $4.31 million +2.2%2.3%3.6 $2.29 2/29/20241,840,000 shares $3.28 million -6.6%2.4%3.5 $1.78 2/15/20241,970,000 shares $3.47 million -9.6%2.6%3.6 $1.76 Get the Latest News and Ratings for CMPX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Compass Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/31/20242,180,000 shares $2.83 million +10.1%2.8%4.1 $1.30 1/15/20241,980,000 shares $3.58 million -12.8%2.6%3.9 $1.81 12/31/20232,270,000 shares $3.54 million +8.1%2.8%4.4 $1.56 12/15/20232,100,000 shares $3.34 million -21.4%2.6%5.9 $1.59 11/30/20232,670,000 shares $4.41 million -10.1%3.3%8.5 $1.65 11/15/20232,970,000 shares $4.40 million +4.2%3.6%10.8 $1.48 10/31/20232,850,000 shares $5.13 million -12.8%3.5%13 $1.80 10/15/20233,270,000 shares $6.25 million -23.2%4.0%13.5 $1.91 9/30/20234,260,000 shares $8.39 million -5.1%5.2%16.5 $1.97 9/15/20234,490,000 shares $9.56 million +1.4%5.5%14.6 $2.13 8/31/20234,430,000 shares $10.32 million -1.1%5.5%8.4 $2.33 8/15/20234,480,000 shares $11.07 million -2.4%5.5%8.1 $2.47 7/31/20234,590,000 shares $13.17 million -1.3%6.0%8 $2.87 7/15/20234,650,000 shares $13.35 million +8.4%6.1%8.1 $2.87 6/30/20234,290,000 shares $13.64 million +93.2%5.9%7.4 $3.18 6/15/20232,220,000 shares $7.28 million +8.8%3.3%3.9 $3.28 5/31/20232,040,000 shares $5.92 million -1.0%3.0%5.9 $2.90 5/15/20232,060,000 shares $6.84 million -5.9%3.1%5.9 $3.32 4/30/20232,190,000 shares $6.59 million +5.3%3.3%6 $3.01 4/15/20232,080,000 shares $6.45 million +4.5%3.1%4.8 $3.10 3/31/20231,990,000 shares $6.51 million -6.6%3.0%4.7 $3.27 3/15/20232,130,000 shares $7.58 million +17.7%3.2%5.7 $3.56 2/28/20231,810,000 shares $6.86 million -18.1%2.7%4.9 $3.79 2/15/20232,210,000 shares $8.80 million +16.3%3.2%6.5 $3.98 1/31/20231,900,000 shares $7.60 million +84.5%2.5%6.2 $4.00 1/15/20231,030,000 shares $5.35 million +10.2%1.4%4.5 $5.19 12/30/2022935,000 shares $4.70 million +197.3%1.2%5.4 $5.03 12/15/2022314,500 shares $1.41 million +112.6%0.4%1.8 $4.49 11/30/2022147,900 shares $607,869.00 +36.2%0.2%0.8 $4.11 11/15/2022108,600 shares $515,850.00 -17.1%0.2%0.6 $4.75 10/31/2022131,000 shares $413,960.00 -21.9%0.2%0.7 $3.16 10/15/2022167,800 shares $523,536.00 -13.2%0.3%1 $3.12 9/30/2022193,400 shares $440,952.00 +271.2%0.4%1.1 $2.28 9/15/202252,100 shares $162,552.00 +143.5%0.1%0.3 $3.12Top 5 AI Stocks to Buy for 2024 (Ad)5 Best AI Stocks to Invest In Investors are getting very rich in AI stocks right now. Wall Street legend is giving away the name and ticker of the little-known AI stock Wall Street is currently buying hand-over-fist.Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In" CMPX Short Interest - Frequently Asked Questions What is Compass Therapeutics' current short interest? Short interest is the volume of Compass Therapeutics shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 1,640,000 shares of CMPX short. 1.90% of Compass Therapeutics' shares are currently sold short. Learn More on Compass Therapeutics' current short interest. What is a good short interest ratio for Compass Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CMPX shares currently have a short interest ratio of 5.0. Learn More on Compass Therapeutics's short interest ratio. What is a good short interest percentage for Compass Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.90% of Compass Therapeutics' floating shares are currently sold short. Is Compass Therapeutics' short interest increasing or decreasing? Compass Therapeutics saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 1,640,000 shares, an increase of 1.2% from the previous total of 1,620,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Compass Therapeutics' float size? Compass Therapeutics currently has issued a total of 137,590,000 shares. Some of Compass Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Compass Therapeutics currently has a public float of 86,210,000 shares. How does Compass Therapeutics' short interest compare to its competitors? 1.90% of Compass Therapeutics' shares are currently sold short. Here is how the short interest of companies compare to Compass Therapeutics: Zura Bio Limited (3.07%), Acumen Pharmaceuticals, Inc. (2.09%), PCB Bancorp (0.61%), Agenus Inc. (16.80%), Innate Pharma S.A. (0.10%), Opthea Limited (0.22%), INmune Bio, Inc. (13.54%), Coherus BioSciences, Inc. (18.91%), Century Therapeutics, Inc. (5.00%), Kodiak Sciences Inc. (3.76%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Compass Therapeutics stock? Short selling CMPX is an investing strategy that aims to generate trading profit from Compass Therapeutics as its price is falling. CMPX shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Compass Therapeutics? A short squeeze for Compass Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CMPX, which in turn drives the price of the stock up even further. How often is Compass Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CMPX, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Zura Bio Short Interest Acumen Pharmaceuticals Short Interest PCB Bancorp Short Interest Agenus Short Interest Innate Pharma Short Interest Opthea Short Interest INmune Bio Short Interest Coherus BioSciences Short Interest Century Therapeutics Short Interest Kodiak Sciences Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CMPX) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersAmazon's betting big on this unknown AI companyManward PressThis Wall Street stock prediction just went viralChaikin AnalyticsTop 5 AI Stocks to Buy for 2024Market Moving TrendsThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportTop 5 Tech Stocks to Buy for 2024Daily Market AlertsWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks News